Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status.
Laczmanska I, Matkowski R, Supplitt S, Karpinski P, Abrahamowska M, Laczmanski L, Maciejczyk A, Czykalko E, Iwaneczko E, Kasprzak P, Szynglarewicz B, Sasiadek M. Laczmanska I, et al. Among authors: supplitt s. Breast Cancer Res Treat. 2024 Nov 23. doi: 10.1007/s10549-024-07544-y. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39579249 No abstract available.
Correction to: The analysis of transcriptomic signature of TNBC-searching for the potential RNA‑based predictive biomarkers to determine the chemotherapy sensitivity.
Supplitt S, Karpinski P, Sasiadek M, Laczmanski L, Kujawa D, Matkowski R, Kasprzak P, Abrahamowska M, Maciejczyk A, Iwaneczko E, Laczmanska I. Supplitt S, et al. J Appl Genet. 2024 Aug 24. doi: 10.1007/s13353-024-00902-y. Online ahead of print. J Appl Genet. 2024. PMID: 39179763 No abstract available.
Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status.
Laczmanska I, Matkowski R, Supplitt S, Karpinski P, Abrahamowska M, Laczmanski L, Maciejczyk A, Czykalko E, Iwaneczko E, Kasprzak P, Szynglarewicz B, Sasiadek M. Laczmanska I, et al. Among authors: supplitt s. Breast Cancer Res Treat. 2024 Dec;208(3):501-510. doi: 10.1007/s10549-024-07441-4. Epub 2024 Jul 30. Breast Cancer Res Treat. 2024. PMID: 39080120 Free PMC article.
Corrigendum to 'Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) - in vitro studies' [Biomed. Pharmacother. 132 (2020) 110883].
Szlasa W, Supplitt S, Drąg-Zalesińska M, Przystupski D, Kotowski K, Szewczyk A, Kasperkiewicz P, Saczko J, Kulbacka J. Szlasa W, et al. Among authors: supplitt s. Biomed Pharmacother. 2021 Jul;139:111694. doi: 10.1016/j.biopha.2021.111694. Epub 2021 May 10. Biomed Pharmacother. 2021. PMID: 33985862 Free article. No abstract available.
Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) - in vitro studies.
Szlasa W, Supplitt S, Drąg-Zalesińska M, Przystupski D, Kotowski K, Szewczyk A, Kasperkiewicz P, Saczko J, Kulbacka J. Szlasa W, et al. Among authors: supplitt s. Biomed Pharmacother. 2020 Dec;132:110883. doi: 10.1016/j.biopha.2020.110883. Epub 2020 Oct 28. Biomed Pharmacother. 2020. PMID: 33113417 Free article.
11 results